Shiro Akinaga
Director Ejecutivo en NANO MRNA CO.,LTD. .
Fortuna: 87 208 $ al 31/05/2024
Cargos activos de Shiro Akinaga
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
NANO MRNA CO.,LTD. | Director/Miembro de la Junta | 01/06/2020 | - |
Director Ejecutivo | 01/12/2022 | - | |
Director Técnico/Científico/I+D | 01/09/2020 | - | |
Presidente | 01/12/2022 | - | |
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | Presidente | 01/03/2017 | - |
Director Ejecutivo | 01/03/2017 | - | |
Director/Miembro de la Junta | 01/03/2017 | - | |
Director Técnico/Científico/I+D | 01/03/2017 | 01/11/2018 | |
Presidente | 01/11/2018 | - |
Historial de carrera de Shiro Akinaga
Antiguos cargos conocidos de Shiro Akinaga.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
KYOWA KIRIN CO. LTD. | Corporate Officer/Principal | - | - |
Estadísticas
Internacional
Japón | 4 |
Operativa
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sectorial
Health Technology | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
KYOWA KIRIN CO. LTD. | Health Technology |
NANO MRNA CO.,LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | Health Technology |
- Bolsa de valores
- Insiders
- Shiro Akinaga
- Experiencia